To the best of our knowledge, this is the first description of an association of an NF1 pathogenic mutation and VUS in the POLE gene in a patient with a previous diagnosis of MTC without mutation of the RET gene. This evidence concerns the gene POLE and medullary thyroid gland carcinoma.